1, Dean Diagnostics (28.30 +1.25%, diagnostic shares): the layout of high-end precision diagnostic technology platform, cooperation *** build business growth is rapid, has been in a number of tertiary hospitals customer extension *** build precision platform.
2, the United States and Hong Kong Biological (23.45 +0.04%, diagnosis): has obtained 145 in vitro diagnostic reagents product registration certificates, covering biochemical, blood cells and other fields.
3, Jiuzhou Tong (20.04 +0.50%, shares): its wholly owned subsidiary of the good pharmacist pharmacy and Kang Sheng medicine signed a strategic cooperation framework agreement, plans to gradually realize the Kang Yuan series of medicines within three years, the health food series for cooperation.
4, Lucking health (6.26 -1.11%, diagnosis): the company is one of the earlier engaged in the development and production of home sauna equipment, is to promote the health of the sauna into the domestic ordinary family of the forerunner. The main products mainly include home far-infrared sauna room and portable sauna products two categories.
5, Beida medicine (000788): the acquisition of Beida medicine to complete the business expansion. The company in 2011 to the Beida international hospital group directional hair acquisition to buy 100% of the equity of Beida medicine. North medicine medicine and its subsidiaries from 2011 into the company statement. The company added into the drug, medical equipment sales and distribution business, the pharmaceutical industry chain is further extended.
Baidu Encyclopedia-Health